Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

The science behind space-based medicine is a bit of a slow-burner, but it’s on the launchpad

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

When it comes to influenza, chicken egg-based vaccines have achieved much, but emerging approaches are ready to fly the coop.

It’s been 200 years since the death of Edward Jenner – but how best to celebrate his achievement?

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

The International Vaccine Institute’s Youngmi Cho is on a mission to protect communities against diseases of poverty